The Anti-Factor Xa Range For Low Molecular Weight Heparin Thromboprophylaxis
- PMID: 26733269
- PMCID: PMC4691677
- DOI: 10.4081/hr.2015.5844
The Anti-Factor Xa Range For Low Molecular Weight Heparin Thromboprophylaxis
Abstract
Low molecular weight heparins (LMWHs) are now the mainstay option in the prevention and treatment of venous thromboembolism. In some patients receiving therapeutic doses of LMWH, activity can be measured by quantifying the presence of Anti-factor Xa (AFXa) for dose adjustment. However, currently there are no guidelines for LMWH monitoring in patients on thromboprophylactic, doses, despite certain patient populations may be at risk of suboptimal dosing. This review found that while the AFXa ranges for therapeutic levels of LMWHs are relatively well defined in the literature, prophylactic ranges are much less clear, thus making it difficult to interpret current research data. From the studies published to date, we concluded that a reasonable AFXa target range for LMWH deep venous thromboses prophylaxis might be 0.2-0.5 IU/mL.
Keywords: Low molecular weight heparin; anti-factor Xa; venous thromboembolism.
Conflict of interest statement
Conflict of interest: the authors declare no potential conflict of interest.
References
-
- Hirsh J, Warkentin TE, Shaughnessy SG, et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001;119:64S-94S. - PubMed
-
- Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:381S-453S. - PubMed
-
- Nutescu EA, Spinler SA, Wittkowsky A, Dager WE. Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings. Ann Pharmacother 2009;43:1064-83. - PubMed
-
- Lim W. Using low molecular weight heparin in special patient populations. J Thromb Thrombolysis 2010;29:233-40. - PubMed
-
- Barras M. Anti-Xa assays. Australian Prescriber 2013;36:4.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources